ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Experts Raise Questions About Influential Swedish Trial Of Mammography Screening.

May 11, 2007

In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year

December 8, 1995

Funding Opportunities (8-page issue).

April 18, 2003

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

NCI-Approved Clinical Trials

August 31, 2001